No connection

Search Results

IMCC vs SXTC

IMCC
IM Cannabis Corp.
BEARISH
Price
$0.36
Market Cap
$2.2M
Sector
Healthcare
AI Confidence
95%
SXTC
China SXT Pharmaceuticals, Inc.
BEARISH
Price
$2.06
Market Cap
$2.0M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
IMCC
--
SXTC
--
Forward P/E
IMCC
-0.28
SXTC
--
P/B Ratio
IMCC
-0.8
SXTC
0.08
P/S Ratio
IMCC
0.04
SXTC
1.28
EV/EBITDA
IMCC
-3.49
SXTC
2.22

Profitability

Gross Margin
IMCC
17.7%
SXTC
21.74%
Operating Margin
IMCC
-31.42%
SXTC
-1011.69%
Profit Margin
IMCC
-20.68%
SXTC
0.0%
ROE
IMCC
--
SXTC
-50.3%
ROA
IMCC
-10.92%
SXTC
-18.27%

Growth

Revenue Growth
IMCC
17.6%
SXTC
-24.5%
Earnings Growth
IMCC
--
SXTC
--

Financial Health

Debt/Equity
IMCC
--
SXTC
0.06
Current Ratio
IMCC
0.67
SXTC
4.37
Quick Ratio
IMCC
0.41
SXTC
4.04

Dividends

Dividend Yield
IMCC
--
SXTC
--
Payout Ratio
IMCC
0.0%
SXTC
0.0%

AI Verdict

IMCC BEARISH

IMCC exhibits severe financial distress, characterized by a Piotroski F-Score of 4/9 and the absence of a Graham Number or Altman Z-Score due to negative equity (Price/Book: -0.80). While the company has shown recent revenue growth of 17.6% and a series of EPS 'beats,' these are marginal improvements on a foundation of deep losses and negative margins. The catastrophic 5-year price decline of 99.9% and a current ratio of 0.67 indicate a high risk of insolvency and a lack of investor confidence.

Strengths
Positive YoY revenue growth of 17.60%
Recent quarterly EPS beats (3 of last 4 quarters)
Extremely low Price/Sales ratio (0.04)
Risks
Negative equity as indicated by Price/Book of -0.80
Severe liquidity risk with a Current Ratio of 0.67 and Quick Ratio of 0.41
Persistent negative operating margins (-31.42%)
SXTC BEARISH

SXTC presents a profile of a company in a catastrophic financial death spiral, despite a Piotroski F-Score of 5/9 suggesting baseline stability. The stock has collapsed from a 52-week high of $1047.00 to $2.06, representing a near-total loss of shareholder value. While the balance sheet shows low debt and high liquidity (Current Ratio 4.37), the operational reality is dire with an operating margin of -1011.69% and declining revenues. The extreme Price-to-Book ratio of 0.08 indicates the market has almost entirely discounted the company's asset value.

Strengths
Very low Debt/Equity ratio (0.06)
Strong short-term liquidity (Current Ratio 4.37)
Piotroski F-Score of 5/9 indicates stable accounting health
Risks
Catastrophic operating losses (Operating Margin -1011.69%)
Severe revenue contraction (-24.50% YoY)
Extreme price volatility and historical collapse (-98.7% 1Y return)

Compare Another Pair

IMCC vs SXTC: Head-to-Head Comparison

This page compares IM Cannabis Corp. (IMCC) and China SXT Pharmaceuticals, Inc. (SXTC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile